Physician profile
David A Sieber
NPI 1760645022
$194,593.81
in general payments reported to CMS, 2019-2025
20 companies · $2,878 in 2025
The $2,878 reported for 2025 was more than what 87% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42K · 2020: $26K · 2021: $1,785 · 2022: $107K · 2023: $1,195 · 2024: $13K · 2025: $2,878.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,600 · Food and Beverage: $6,481 · Travel and Lodging: $3,025 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,600.00 |
| Food and Beverage | $6,480.73 |
| Travel and Lodging | $3,025.00 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Innovation Associates, INC. | $104,375.13 | 2022 | |
| Allergan, INC. | $52,824.76 | 2019-2022 | |
| Galderma Laboratories, L.P. | $14,130.91 | 2019-2025 | |
| Abbvie INC. | $7,804.00 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Motiva USA, LLC | $6,509.60 | 2024-2025 | |
| Sientra, INC. | $4,352.16 | 2019-2022 | |
| Davol INC. | $1,608.98 | 2022-2025 | Phasix Mesh |
| Revance Therapeutics, INC. | $777.37 | 2024-2025 | Daxxify |
| Tepha INC | $619.43 | 2019-2020 | |
| Mentor Worldwide LLC | $424.63 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Tela Bio, INC. | $390.69 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Solta Medical, A Division of Bausch Health US, LLC | $361.69 | 2019-2023 | |
| Musculoskeletal Transplant Foundation INC. | $114.98 | 2022 | |
| Omeros Corporation | $87.35 | 2020 | |
| Neuronetics, INC. | $62.47 | 2024 | Neurostar Tms Therapy System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $45.40 | 2021 | |
| Merz North America, INC. | $43.12 | 2023-2024 | |
| Becton, Dickinson and Company | $23.79 | 2025 | Galaflex |
| Vertex Pharmaceuticals Incorporated | $23.57 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $13.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sieber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.